TK has been hanging off pushing the button for a while.
Odd timing strategically, seems like a bit of an afterthought. Must’ve thought FDA was a sure thing, then when it didn’t happen as he planned, pushed the execution of options to July 2020 for tax purposes.
Wonder what the upcoming RAP quarterly is looking like...
Ann: Change of Director's Interest Notice, page-59
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #